June 6 (Reuters) - Albany Molecular Research Inc
* AMRI signs definitive agreement to be acquired by the Carlyle Group and GTCR for $21.75 per share in cash
* Deal for $21.75 per share in cash.
* Transaction will be financed through a combination of debt and equity financing
* Agreement was unanimously approved by AMRI's board of directors which has recommended that shareholders vote in favor of transaction
* There is no financing condition to obligations of equity sponsors to consummate transaction
* Carlyle and GTCR have received debt financing commitments to finance transaction Source text for Eikon: Further company coverage: